Mitochondrial Dysfunction

R&D

Partner Content

Uncover mitochondrial pathogenic mechanisms to show clinical efficacy for regulatory success

Events

Partner Content

Therapies for mitochondrial dysfunction

News

AI-powered drug discovery company Iambic Therapeutics has announced the terms of its Nasdaq IPO, pitching at a valuation of more than $800m.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.